These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
345 related articles for article (PubMed ID: 32690435)
21. Current Status of Cardiac Regenerative Therapy Using Induced Pluripotent Stem Cells. Sugiura T; Shahannaz DC; Ferrell BE Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891960 [TBL] [Abstract][Full Text] [Related]
22. The electrophysiological development of cardiomyocytes. Liu J; Laksman Z; Backx PH Adv Drug Deliv Rev; 2016 Jan; 96():253-73. PubMed ID: 26788696 [TBL] [Abstract][Full Text] [Related]
23. A Universal and Robust Integrated Platform for the Scalable Production of Human Cardiomyocytes From Pluripotent Stem Cells. Fonoudi H; Ansari H; Abbasalizadeh S; Larijani MR; Kiani S; Hashemizadeh S; Zarchi AS; Bosman A; Blue GM; Pahlavan S; Perry M; Orr Y; Mayorchak Y; Vandenberg J; Talkhabi M; Winlaw DS; Harvey RP; Aghdami N; Baharvand H Stem Cells Transl Med; 2015 Dec; 4(12):1482-94. PubMed ID: 26511653 [TBL] [Abstract][Full Text] [Related]
24. Functional integration of electrically active cardiac derivatives from genetically engineered human embryonic stem cells with quiescent recipient ventricular cardiomyocytes: insights into the development of cell-based pacemakers. Xue T; Cho HC; Akar FG; Tsang SY; Jones SP; Marbán E; Tomaselli GF; Li RA Circulation; 2005 Jan; 111(1):11-20. PubMed ID: 15611367 [TBL] [Abstract][Full Text] [Related]
25. Matrigel Mattress: A Method for the Generation of Single Contracting Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes. Feaster TK; Cadar AG; Wang L; Williams CH; Chun YW; Hempel JE; Bloodworth N; Merryman WD; Lim CC; Wu JC; Knollmann BC; Hong CC Circ Res; 2015 Dec; 117(12):995-1000. PubMed ID: 26429802 [TBL] [Abstract][Full Text] [Related]
26. Human cardiomyocyte generation from pluripotent stem cells: A state-of-art. Talkhabi M; Aghdami N; Baharvand H Life Sci; 2016 Jan; 145():98-113. PubMed ID: 26682938 [TBL] [Abstract][Full Text] [Related]
27. Pluripotent stem cell-derived cardiomyocytes for treatment of cardiomyopathic damage: Current concepts and future directions. Garbern JC; Escalante GO; Lee RT Trends Cardiovasc Med; 2021 Feb; 31(2):85-90. PubMed ID: 31983535 [TBL] [Abstract][Full Text] [Related]
28. Arrhythmogenicity Test Based on a Human-Induced Pluripotent Stem Cell (iPSC)-Derived Cardiomyocyte Layer. Slotvitsky M; Tsvelaya V; Frolova S; Dementyeva E; Agladze K Toxicol Sci; 2019 Mar; 168(1):70-77. PubMed ID: 30388253 [TBL] [Abstract][Full Text] [Related]
38. Derivation and cardiomyocyte differentiation of induced pluripotent stem cells from heart failure patients. Zwi-Dantsis L; Huber I; Habib M; Winterstern A; Gepstein A; Arbel G; Gepstein L Eur Heart J; 2013 Jun; 34(21):1575-86. PubMed ID: 22621821 [TBL] [Abstract][Full Text] [Related]
39. Human pluripotent stem cell-based approaches for myocardial repair: from the electrophysiological perspective. Poon E; Kong CW; Li RA Mol Pharm; 2011 Oct; 8(5):1495-504. PubMed ID: 21879736 [TBL] [Abstract][Full Text] [Related]
40. The Role of Large Animal Models in Cardiac Regeneration Research Using Human Pluripotent Stem Cell-Derived Cardiomyocytes. Cheng YY; Hu YF; Hsieh PC Curr Cardiol Rep; 2023 May; 25(5):325-331. PubMed ID: 37074564 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]